A Phase III, Randomized, Double -Blind, Placebo-controlled Trial to Evaluate Immunogenicity and Safety of the Gam-COVID-Vac Combined Vector Vaccine in Prophylactic Treatment for SARS-СoV-2 Infection in the United Arab Emirates
Latest Information Update: 06 Dec 2022
At a glance
- Drugs COVID-19 vaccine-Gamaleya National Research Center of Epidemiology and Microbiology (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms SPUTNIK-UAE
- 14 Dec 2020 New trial record